 |
|
Interaction of Duloxetine and Warfarin Causing Severe Elevation of International Normalized Ratio
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: We describe what we believe is the first report of a drug interaction between duloxetine hydrochloride and warfarin. The patient has provided consent for publication of this report, and it has received institutional review board approval.
Report of a Case
A 44-year-old woman, self-designated as white, homozygous for the factor V Leiden mutation, had been treated uneventfully for 1 year after an ischemic stroke with warfarin, 7.5 to 10 mg/d (mean international normalized ratio [INR], 2.2 [SD, 0.5]) (Figure). She had normal levels of protein C, protein S, homocysteine, and lipoprotein(a); homozygous wild-type genotypes for prothrombin (G20210A), MTHFR (C677T), PAI-1 (4G/5G), and platelet glycoprotein PL A1/A2; and no lupus anticoagulant or anticardiolipin antibodies. She had increased factor XI (179% [upper normal limit, 150%]) and plasminogen activator inhibitor activity (71.7 IU/mL [upper normal limit, 21.2]). She was being treated for poststroke seizures, migraine prophylaxis, panic disorder, and bronchospasm. She had . . . [Full Text of this Article]
Charles J. Glueck, MD
glueckch@healthall.com
Qasim Khalil, MD;
Magdalena Winiarska, MD;
Ping Wang, PhD
Cholesterol Center
Jewish Hospital
Cincinnati, Ohio
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
A Case of Apical Ballooning Cardiomyopathy Associated with Duloxetine
Bergman et al.
ANN INTERN MED 2008;149:218-219.
FULL TEXT
Is there a place for {blacktriangledown}duloxetine?
DTB 2007;45:29-32.
ABSTRACT
| FULL TEXT
|
